Opendoor Stock Surges After CEO Buy-In

Opendoor stock jumped after CEO Kaz Nejatian bought $1,003,750 of shares and founders rejoined the board, spurring volatile trader focus on Q3 guidance.

November 14, 2025·2 min read
View all news articles
House-shaped vault fracturing to signal Opendoor stock leadership reset and CEO buy; flat vector subtle shadow.

KEY TAKEAWAYS

  • CEO Kaz Nejatian bought 125,000 shares for $1,003,750 on Nov. 12, 2025.
  • Co-founders Keith Rabois and Eric Wu rejoined the board; Rabois became chairman.
  • Q3 2025 guidance set revenue $800-$875 million and forecast negative adjusted EBITDA.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Opendoor Technologies (NASDAQ: OPEN) stock surged more than 200% in the past 72 hours after CEO Kaz Nejatian bought company shares and announced sweeping operational cuts and an AI-focused turnaround, moves management says are central to stabilizing results.

Leadership Change and Operational Reset

In September 2025, Opendoor appointed Kaz Nejatian as CEO, with co-founders Keith Rabois and Eric Wu rejoining the board and Rabois becoming chairman. On November 12, Nejatian purchased 125,000 shares for $1 million, a move investors saw as a strong vote of confidence that helped fuel the recent rally.

Nejatian quickly implemented a major organizational reset, cutting headcount by about 20%, ending contracts with outside consultants, and requiring employees to return to full-time office work. He also directed teams to “default to AI” to accelerate pricing decisions and property matching. On the November 6 earnings call, Nejatian said, "Opendoor is an 'AI company.'" Management views these personnel and process changes as key to reshaping costs and speeding transaction volume.

Financial Outlook and Market Response

On the November 6 earnings call, Opendoor gave Q3 2025 guidance of revenue between $800 million and $875 million and said adjusted EBITDA would be negative. Management attributed the outlook to continued housing market weakness, citing high mortgage rates and low transaction volumes.

Nejatian set a goal for the company to reach profitability by the end of 2026, linking it to AI-driven operational improvements and strict cost discipline. Executives acknowledge that achieving this depends on executing the new operating model and translating AI initiatives into measurable margin gains.

Despite the recent share surge, analysts remain skeptical. The consensus rating is "Sell" with a 12-month price target of $1.88, reflecting concerns about ongoing losses and execution risks. The combination of founder involvement and the CEO’s insider purchase has created a new narrative for investors, but the company’s Q3 guidance and profitability target will be the immediate tests of the turnaround. Analysts say the rally remains vulnerable to housing market softness and the risks of rapid organizational change.

HIGH POTENTIAL TRADES SENT DIRECTLY TO YOUR INBOX

Add your email to receive our free daily newsletter. No spam, unsubscribe anytime.

Or subscribe with

Read other top news stories

StubHub Q3 Earnings: Stock Falls After Guidance Withheld

StubHub Q3 earnings showed revenue growth but a large IPO-related net loss and no Q4 guidance, prompting a steep share selloff and pressured positioning.

Lundbeck Bid for Avadel Tops Alkermes Deal

Lundbeck Bid for Avadel raises takeover stakes by topping Alkermes' signed agreement and could force matching or renegotiation that reshapes deal certainty

Merck To Acquire Cidara Therapeutics

Merck to acquire Cidara strengthens its antiviral and respiratory pipeline ahead of Keytruda patent expiry and shifts near-term trader positioning.

Walmart CEO Transition Names John Furner

Walmart CEO transition names John Furner; the board appointment and handover aim to preserve operational continuity and limit governance uncertainty.

AI Stock Sell-Off Sends Global Markets Lower

AI stock sell-off triggered a Nasdaq-led rout, pressured futures and cut December Fed rate-cut odds to 50%, while China investment fell 1.7%.

Novo Nordisk Board Reshuffle Names Sorensen

Novo Nordisk Board Reshuffle installed Lars Rebien Sorensen on Nov. 14, 2025 and raises governance risk that could unsettle shareholder confidence.